RAPHAEL EREZ (Chief Executive Officer) received a stock award from DARIOHEALTH CORP.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/28/2026ACC: 0001104659-26-111343
DirectorOfficer10% Owner· Chief Executive Officer
Since Jul 2018
+297.55K
Net shares
Net buyer
$11.1K
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
297.58K acquired · 30.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+579.00
Price / share
$19.10
Trade value
$11.06K
% of position
0.4%
8/12/2024
156.85K→157.43K
Common Stock
Direct
Shares
+297K
Price / share
—
Trade value
—
% of position
188.7%
9/24/2026
157.43K→454.43K
Total
Net shares
+297.58K
Net value
$11.06K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/12/2024 | C · Conversion | +579.00 | $19.10 | $11.06K | 0.4% | 156.85K | 157.43K |
| Common Stock Direct | 9/24/2026 | A · Award | +297K | — | — | 188.7% | 157.43K | 454.43K |
| Total | +297.58K | $11.06K | ||||||
Derivative Transactions1
Series B-2 Preferred Stock
Direct
Converts to
Common Stock
579.00 shares
Shares
−30.00
Strike price
1000
Held after
0.00
Exercisable
—
8/12/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series B-2 Preferred Stock Direct | Common Stock579.00 shares | 8/12/2024 | C · Conversion | −30.00 | 1000 | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.89K
Total
1.89K indirect1.89K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.89K | Indirect |
| Total | 1.89K | 1.89K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported